MED1 and metabolic dysfunction-associated steatotic liver disease: THRA and NAFLD are directly related through the receptor’s activity and its interaction with coactivator protein TRAP220 (Thyroid Hormone Receptor–Associated Protein 220), a factor of the Mediator complex [39].